oxybutynin has been researched along with Facial Neoplasms in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Facial Neoplasms: New abnormal growth of tissue in the FACE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tekin, B | 1 |
| Karadag, AS | 1 |
| Koska, MC | 1 |
1 other study available for oxybutynin and Facial Neoplasms
| Article | Year |
|---|---|
Oral oxybutynin for multiple eccrine hidrocystomas.
Topics: Administration, Oral; Dose-Response Relationship, Drug; Drug Administration Schedule; Esthetics; Fac | 2017 |